Evidence map›Paper›PMID 39044830›Full record

ArticleFrontiers in immunology2024

ATP-P2X7R pathway activation limits the Tfh cell compartment during pediatric RSV infection.

Constanza Russo, Silvina Raiden, Silvia Algieri, María José Bruera, Norberto De Carli, Mariam Sarli, Héctor Cairoli, Leonardo De Lillo, Ivanna Morales, Vanesa Seery and 13 more

Abstract read
In one paragraph

Article in Frontiers in immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Constanza RussoInstituto de Investigaciones Biomédicas en Retrovirus y SIDA, Facultad de Medicina, Universidad de Buenos Aires- Consejo Nacional de Investigaciones Científicas y Técnicas, Buenos Aires, Argentina.
Silvina RaidenDepartamento de Medicina, Hospital General de Niños Pedro de Elizalde, Buenos Aires, Argentina.
Silvia AlgieriServicio de Pediatría, Hospital Nacional Profesor Alejandro Posadas, Buenos Aires, Argentina.
María José BrueraServicio de Pediatría, Hospital Nacional Profesor Alejandro Posadas, Buenos Aires, Argentina.
Norberto De CarliServicio de Pediatría, Clínica del Niño de Quilmes, Buenos Aires, Argentina.
Mariam SarliServicio de Pediatría, Hospital Nacional Profesor Alejandro Posadas, Buenos Aires, Argentina.
Héctor CairoliDepartamento de Medicina, Hospital General de Niños Pedro de Elizalde, Buenos Aires, Argentina.
Leonardo De LilloDepartamento de Medicina, Hospital General de Niños Pedro de Elizalde, Buenos Aires, Argentina.
Ivanna MoralesDepartamento de Medicina, Hospital General de Niños Pedro de Elizalde, Buenos Aires, Argentina.
Vanesa SeeryInstituto de Investigaciones Biomédicas en Retrovirus y SIDA, Facultad de Medicina, Universidad de Buenos Aires- Consejo Nacional de Investigaciones Científicas y Técnicas, Buenos Aires, Argentina.
Adrián OteroInstituto de Investigaciones Biomédicas en Retrovirus y SIDA, Facultad de Medicina, Universidad de Buenos Aires- Consejo Nacional de Investigaciones Científicas y Técnicas, Buenos Aires, Argentina.
Inés SananezInstituto de Investigaciones Biomédicas en Retrovirus y SIDA, Facultad de Medicina, Universidad de Buenos Aires- Consejo Nacional de Investigaciones Científicas y Técnicas, Buenos Aires, Argentina.
Nancy SimazServicio de Pediatría, Hospital Nacional Profesor Alejandro Posadas, Buenos Aires, Argentina.
Gisela AlfieroServicio de Pediatría, Hospital Nacional Profesor Alejandro Posadas, Buenos Aires, Argentina.
Gabriela RubinoServicio de Pediatría, Hospital Nacional Profesor Alejandro Posadas, Buenos Aires, Argentina.
Néstor MoyaServicio de Pediatría, Hospital Nacional Profesor Alejandro Posadas, Buenos Aires, Argentina.
Luisa Aedo PortelaServicio de Pediatría, Clínica del Niño de Quilmes, Buenos Aires, Argentina.
Mauro HerreroInstituto de Investigaciones Biomédicas en Retrovirus y SIDA, Facultad de Medicina, Universidad de Buenos Aires- Consejo Nacional de Investigaciones Científicas y Técnicas, Buenos Aires, Argentina.
Marina BlancoInstituto de Investigaciones Biomédicas en Retrovirus y SIDA, Facultad de Medicina, Universidad de Buenos Aires- Consejo Nacional de Investigaciones Científicas y Técnicas, Buenos Aires, Argentina.
Misael Salcedo PereiraServicio de Pediatría, Clínica del Niño de Quilmes, Buenos Aires, Argentina.
Fernando FerreroDepartamento de Medicina, Hospital General de Niños Pedro de Elizalde, Buenos Aires, Argentina.
Jorge GeffnerInstituto de Investigaciones Biomédicas en Retrovirus y SIDA, Facultad de Medicina, Universidad de Buenos Aires- Consejo Nacional de Investigaciones Científicas y Técnicas, Buenos Aires, Argentina.
Lourdes ArruvitoInstituto de Investigaciones Biomédicas en Retrovirus y SIDA, Facultad de Medicina, Universidad de Buenos Aires- Consejo Nacional de Investigaciones Científicas y Técnicas, Buenos Aires, Argentina.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Follicular helper T cells (Tfh) are pivotal in B cell responses. Activation of the purinergic receptor P2X7 on Tfh cells regulates their activity. We investigated the ATP-P2X7R axis in circulating Tfh (cTfh) cells during Respiratory Syncytial Virus (RSV) infection. Methods: We analyzed two cohorts: children with RSV infection (moderate, n=30; severe, n=21) and healthy children (n=23). We utilized ELISA to quantify the levels of PreF RSV protein-specific IgG antibodies, IL-21 cytokine, and soluble P2X7R (sP2X7R) in both plasma and nasopharyngeal aspirates (NPA). Additionally, luminometry was employed to determine ATP levels in plasma, NPA and supernatant culture. The frequency of cTfh cells, P2X7R expression, and plasmablasts were assessed by flow cytometry. To evaluate apoptosis, proliferation, and IL-21 production by cTfh cells, we cultured PBMCs in the presence of Bz-ATP and/or P2X7R antagonist (KN-62) and a flow cytometry analysis was performed. Results: In children with severe RSV disease, we observed diminished titers of neutralizing anti-PreF IgG antibodies. Additionally, severe infections, compared to moderate cases, were associated with fewer cTfh cells and reduced plasma levels of IL-21. Our investigation revealed dysregulation in the ATP-P2X7R pathway during RSV infection. This was characterized by elevated ATP levels in both plasma and NPA samples, increased expression of P2X7R on cTfh cells, lower levels of sP2X7R, and heightened ATP release from PBMCs upon stimulation, particularly evident in severe cases. Importantly, ATP exposure decreased cTfh proliferative response and IL-21 production, while promoting their apoptosis. The P2X7R antagonist KN-62 mitigated these effects. Furthermore, disease severity positively correlated with ATP levels in plasma and NPA samples and inversely correlated with cTfh frequency. Conclusion: Our findings indicate that activation of the ATP-P2X7R pathway during RSV infection may contribute to limiting the cTfh cell compartment by promoting cell death and dysfunction, ultimately leading to increased disease severity.

Indexed as

Adenosine TriphosphateReceptors, Purinergic P2X7Respiratory Syncytial Virus InfectionsT Follicular Helper CellsAntibodies, ViralChildChild, PreschoolFemaleHumansInfantInterleukin-21InterleukinsMaleRespiratory Syncytial Virus, HumanSignal TransductionAdenosine TriphosphateAntibodies, ViralInterleukin-21InterleukinsP2RX7 protein, humanReceptors, Purinergic P2X7antibodiesATPchildrenRSVTfh cell

Identifiers

PMID39044830
PMCPMC11263008

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.